Forefoot SurgeryAQABNCT07078396
Duration and Quality of 1% Ropivacaine Ankle Blocks
An observational study of Forefoot Surgery, run by Ziekenhuis Oost-Limburg at 1 site in Belgium.
Trial summary
The goal of this observational study is to determine the analgesic duration and analgesic quality of a 1% ropivacaine ankle block in forefoot surgery. Bilateral cases of forefoot surgery, preoperative use of steroids, preexisting lower extremity neuropathy, or failed blocks were not included in this quality… Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Forefoot Surgery
- How many people
- 56 participants
- Where
- 1 siteBelgium
- Study dates
- 1 Dec 2023to 30 Apr 2024
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: Ziekenhuis Oost-Limburg, Genk, Belgium.
Who may be able to join
- Patients who underwent unilateral elective forefoot surgery under ankle block with 1% ropivacaine between December 2023 and April 2024 at Ziekenhuis Oost-Limburg, Genk, Belgium.
Who cannot join
- Bilateral cases of forefoot surgery
- Preoperative use of steroids,
- Preexisting lower extremity neuropathy
- Failed blocks
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Duration and Analgesic Quality of 1% Ropivacaine Ankle Blocks for Forefoot Surgeries - A Retrospective Analysis
The goal of this observational study is to determine the analgesic duration and analgesic quality of a 1% ropivacaine ankle block in forefoot surgery. Bilateral cases of forefoot surgery, preoperative use of steroids, preexisting lower extremity neuropathy, or failed blocks were not included in this quality improvement program.
An ankle block with 1% ropivcaine and patient follow-up is part of the standard practice at Ziekenhuis Oost-Limburg.
- Conditions
- Forefoot Surgery
- Keywords
- Ultrasound-guided, Ankle block, Ropivacaine, Forefoot surgery, Block duration
What is being measured
The primary outcome is the main question the study is designed to answer.
Duration sensory block
Every patient was contacted by phone to assess the duration of analgesia, maximum pain scores within the first 24 hours and patient satisfaction with analgesia on a 10-point visual analog scale (VAS), opioid consumption in the first 24 hours, sleep quality, side effects, and ease of mobilization. If the sensory block had not disappeared at the moment of the survey or if the patient could not be reached, the patient was called again the day after.
Measured: A maximum of 72 hours until return of sensation is expected.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Jul 2025
- Study start1 Dec 2023
- Primary completion24 Apr 2024
- Study completion30 Apr 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Forefoot SurgeryStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 56 participants (actual)
Sponsor and investigators
- Lead sponsor
- Ziekenhuis Oost-Limburg
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Imré Van Herreweghe, Ziekenhuis Oost-Limburg
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07078396
- Sponsor's protocol ID
- AQAB
- Acronym
- AQAB
- Status last verified
- Jul 2025
- First submitted
- 26 Jun 2025
- Last updated
- 22 Jul 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 22 Jul 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Duration and Analgesic Quality of 1% Ropivacaine Ankle Blocks for Forefoot Surgeries - A Retrospective Analysis
- ClinicalTrials.gov ID
- NCT07078396
- Acronym / sponsor ID
- AQAB / AQAB
- Conditions
- Forefoot Surgery
- Keywords
- Ultrasound-guided, Ankle block, Ropivacaine, Forefoot surgery, Block duration
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 56 participants (actual)
- Lead sponsor
- Ziekenhuis Oost-LimburgUniversity, hospital or other
- Study start
- 1 Dec 2023 (actual)
- Primary completion
- 24 Apr 2024 (actual)
- Study completion
- 30 Apr 2024 (actual)
- First posted
- 22 Jul 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this observational study is to determine the analgesic duration and analgesic quality of a 1% ropivacaine ankle block in forefoot surgery. Bilateral cases of forefoot surgery, preoperative use of steroids, preexisting lower extremity neuropathy, or failed blocks were not included in this quality improvement program.
An ankle block with 1% ropivcaine and patient follow-up is part of the standard practice at Ziekenhuis Oost-Limburg.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Ziekenhuis Oost-Limburg, Genk, Belgium.
Key inclusion criteria (1 listed)
- Patients who underwent unilateral elective forefoot surgery under ankle block with 1% ropivacaine between December 2023 and April 2024 at Ziekenhuis Oost-Limburg, Genk, Belgium.
Key exclusion criteria (4 listed)
- Bilateral cases of forefoot surgery
- Preoperative use of steroids,
- Preexisting lower extremity neuropathy
- Failed blocks
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Duration sensory block
Time frame: A maximum of 72 hours until return of sensation is expected.
Every patient was contacted by phone to assess the duration of analgesia, maximum pain scores within the first 24 hours and patient satisfaction with analgesia on a 10-point visual analog scale (VAS), opioid consumption in the first 24 hours, sleep quality, side effects, and ease of mobilization. If the sensory block had not disappeared at the moment of the survey or if the patient could not be reached, the patient was called again the day after.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 22 Jul 2025.
- Individual participant dataSharing planned: No
Related trials for Forefoot Surgery
RecruitingObservational study
Evaluate the Continued Safety and Performance of the Foot and Ankle Products
Hyperpronated Foot, Reconstruction Surgeries of the Foot
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Forefoot Surgery, run by Ziekenhuis Oost-Limburg at 1 site in Belgium.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 22 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Duration sensory block (time frame: A maximum of 72 hours until return of sensation is expected.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jul 2025.